Supportive care in the acute phase of Stevens-Johnson syndrome and toxic epidermal necrolysis : an international, multidisciplinary Delphi-based consensus
© 2021 British Association of Dermatologists..
BACKGROUND: Supportive care is the cornerstone of management of adult and paediatric Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). However, consensus on the modalities of supportive care is lacking.
OBJECTIVES: Our aim in this international multicentric Delphi exercise was to establish a multidisciplinary expert consensus to standardize recommendations regarding supportive care in the acute phase of SJS/TEN.
METHODS: Participants were sent a survey via the online tool SurveyMonkey, consisting of 103 statements organized into 11 topics: multidisciplinary team composition, suspect drug management, infection prevention, fluid resuscitation and prevention of hypothermia, nutritional support, pain and psychological distress management, management of acute respiratory failure, local skincare, ophthalmological management, management of other mucosa, and additional measures. Participants evaluated the level of appropriateness of each statement on a scale of 1 (extremely inappropriate) to 9 (extremely appropriate). The results were analysed according to the RAND/UCLA Appropriateness Method.
RESULTS: Forty-five participants from 13 countries (on three continents) participated. After the first round, a consensus was obtained for 82.5% of the 103 initially proposed statements. After the second round, a final consensus was obtained for 102 statements.
CONCLUSIONS: We have reached an international Delphi-based consensus on best supportive care practice for SJS/TEN. Our expert consensus should help guide physicians in treating patients with SJS/TEN and thereby improve short-term prognosis and the risk of sequelae.
| Errataetall: |
CommentIn: Br J Dermatol. 2021 Sep;185(3):484-486. - PMID 34224137 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:185 |
|---|---|
| Enthalten in: |
The British journal of dermatology - 185(2021), 3 vom: 03. Sept., Seite 616-626 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Brüggen, M-C [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 20.09.2021 Date Revised 20.09.2021 published: Print-Electronic CommentIn: Br J Dermatol. 2021 Sep;185(3):484-486. - PMID 34224137 Citation Status MEDLINE |
|---|
| doi: |
10.1111/bjd.19893 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM322151457 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM322151457 | ||
| 003 | DE-627 | ||
| 005 | 20231225181427.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/bjd.19893 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1073.xml |
| 035 | |a (DE-627)NLM322151457 | ||
| 035 | |a (NLM)33657677 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Brüggen, M-C |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Supportive care in the acute phase of Stevens-Johnson syndrome and toxic epidermal necrolysis |b an international, multidisciplinary Delphi-based consensus |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 20.09.2021 | ||
| 500 | |a Date Revised 20.09.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentIn: Br J Dermatol. 2021 Sep;185(3):484-486. - PMID 34224137 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2021 British Association of Dermatologists. | ||
| 520 | |a BACKGROUND: Supportive care is the cornerstone of management of adult and paediatric Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). However, consensus on the modalities of supportive care is lacking | ||
| 520 | |a OBJECTIVES: Our aim in this international multicentric Delphi exercise was to establish a multidisciplinary expert consensus to standardize recommendations regarding supportive care in the acute phase of SJS/TEN | ||
| 520 | |a METHODS: Participants were sent a survey via the online tool SurveyMonkey, consisting of 103 statements organized into 11 topics: multidisciplinary team composition, suspect drug management, infection prevention, fluid resuscitation and prevention of hypothermia, nutritional support, pain and psychological distress management, management of acute respiratory failure, local skincare, ophthalmological management, management of other mucosa, and additional measures. Participants evaluated the level of appropriateness of each statement on a scale of 1 (extremely inappropriate) to 9 (extremely appropriate). The results were analysed according to the RAND/UCLA Appropriateness Method | ||
| 520 | |a RESULTS: Forty-five participants from 13 countries (on three continents) participated. After the first round, a consensus was obtained for 82.5% of the 103 initially proposed statements. After the second round, a final consensus was obtained for 102 statements | ||
| 520 | |a CONCLUSIONS: We have reached an international Delphi-based consensus on best supportive care practice for SJS/TEN. Our expert consensus should help guide physicians in treating patients with SJS/TEN and thereby improve short-term prognosis and the risk of sequelae | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 700 | 1 | |a Le, S T |e verfasserin |4 aut | |
| 700 | 1 | |a Walsh, S |e verfasserin |4 aut | |
| 700 | 1 | |a Toussi, A |e verfasserin |4 aut | |
| 700 | 1 | |a de Prost, N |e verfasserin |4 aut | |
| 700 | 1 | |a Ranki, A |e verfasserin |4 aut | |
| 700 | 1 | |a Didona, B |e verfasserin |4 aut | |
| 700 | 1 | |a Colin, A |e verfasserin |4 aut | |
| 700 | 1 | |a Horváth, B |e verfasserin |4 aut | |
| 700 | 1 | |a Brezinova, E |e verfasserin |4 aut | |
| 700 | 1 | |a Milpied, B |e verfasserin |4 aut | |
| 700 | 1 | |a Moss, C |e verfasserin |4 aut | |
| 700 | 1 | |a Bodemer, C |e verfasserin |4 aut | |
| 700 | 1 | |a Meyersburg, D |e verfasserin |4 aut | |
| 700 | 1 | |a Salavastru, C |e verfasserin |4 aut | |
| 700 | 1 | |a Tiplica, G-S |e verfasserin |4 aut | |
| 700 | 1 | |a Howard, E |e verfasserin |4 aut | |
| 700 | 1 | |a Bequignon, E |e verfasserin |4 aut | |
| 700 | 1 | |a Bouwes Bavinck, J N |e verfasserin |4 aut | |
| 700 | 1 | |a Newman, J |e verfasserin |4 aut | |
| 700 | 1 | |a Gueudry, J |e verfasserin |4 aut | |
| 700 | 1 | |a Nägeli, M |e verfasserin |4 aut | |
| 700 | 1 | |a Zaghbib, K |e verfasserin |4 aut | |
| 700 | 1 | |a Pallesen, K |e verfasserin |4 aut | |
| 700 | 1 | |a Bygum, A |e verfasserin |4 aut | |
| 700 | 1 | |a Joly, P |e verfasserin |4 aut | |
| 700 | 1 | |a Wolkenstein, P |e verfasserin |4 aut | |
| 700 | 1 | |a Chua, S-L |e verfasserin |4 aut | |
| 700 | 1 | |a Le Floch, R |e verfasserin |4 aut | |
| 700 | 1 | |a Shear, N H |e verfasserin |4 aut | |
| 700 | 1 | |a Chu, C-Y |e verfasserin |4 aut | |
| 700 | 1 | |a Hama, N |e verfasserin |4 aut | |
| 700 | 1 | |a Abe, R |e verfasserin |4 aut | |
| 700 | 1 | |a Chung, W-H |e verfasserin |4 aut | |
| 700 | 1 | |a Shiohara, T |e verfasserin |4 aut | |
| 700 | 1 | |a Ardern-Jones, M |e verfasserin |4 aut | |
| 700 | 1 | |a Romanelli, P |e verfasserin |4 aut | |
| 700 | 1 | |a Phillips, E J |e verfasserin |4 aut | |
| 700 | 1 | |a Stern, R S |e verfasserin |4 aut | |
| 700 | 1 | |a Cotliar, J |e verfasserin |4 aut | |
| 700 | 1 | |a Micheletti, R G |e verfasserin |4 aut | |
| 700 | 1 | |a Brassard, A |e verfasserin |4 aut | |
| 700 | 1 | |a Schulz, J T |e verfasserin |4 aut | |
| 700 | 1 | |a Dodiuk-Gad, R P |e verfasserin |4 aut | |
| 700 | 1 | |a Dominguez, A R |e verfasserin |4 aut | |
| 700 | 1 | |a Paller, A S |e verfasserin |4 aut | |
| 700 | 1 | |a Seminario-Vidal, L |e verfasserin |4 aut | |
| 700 | 1 | |a Mostaghimi, A |e verfasserin |4 aut | |
| 700 | 1 | |a Noe, M H |e verfasserin |4 aut | |
| 700 | 1 | |a Worswick, S |e verfasserin |4 aut | |
| 700 | 1 | |a Tartar, D |e verfasserin |4 aut | |
| 700 | 1 | |a Sheridan, R |e verfasserin |4 aut | |
| 700 | 1 | |a Kaffenberger, B H |e verfasserin |4 aut | |
| 700 | 1 | |a Shinkai, K |e verfasserin |4 aut | |
| 700 | 1 | |a Maverakis, E |e verfasserin |4 aut | |
| 700 | 1 | |a French, L E |e verfasserin |4 aut | |
| 700 | 1 | |a Ingen-Housz-Oro, S |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The British journal of dermatology |d 1951 |g 185(2021), 3 vom: 03. Sept., Seite 616-626 |w (DE-627)NLM000000361 |x 1365-2133 |7 nnns |
| 773 | 1 | 8 | |g volume:185 |g year:2021 |g number:3 |g day:03 |g month:09 |g pages:616-626 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/bjd.19893 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 185 |j 2021 |e 3 |b 03 |c 09 |h 616-626 | ||